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Key points
† Femoral block spares
opioids and has better
functional recovery
profile.
† Preoperative walking
capacity and early
postoperative walking
time predict short-term
recovery.
† Walk tests can be reliable
indicators of knee
function recovery.
Background. Capacity to ambulate represents an important milestone in the recovery
process after total knee arthroplasty (TKA). The purpose of this study was to determine
the analgesic effect of two analgesic techniques and their impact on functional walking
capacity as a measure of surgical recovery.
Methods. Forty ASA II–III subjects undergoing TKA were enrolled in a randomized, double-
blind, single-centre study receiving 48 h postoperative analgesia with either periarticular
infiltration of local anaesthetic (Group I) or continuous femoral nerve block (Group F).
Breakthrough pain relief was achieved with patient-controlled analgesia (PCA) morphine.
The main outcome was postoperative morphine consumption. Early (postoperative days
1–3) and late (6 weeks) functional walking capacity (2 and 6 min walk tests, 2MWT and
6MWT, respectively), degree of physical activity (CHAMPS), health-related quality of life
(SF-12), and clinical indicators of knee function (WOMAC, Knee Society evaluation, and
range of motion) were measured.
Results. Patients in Group F used the PCA less (P¼0.02) to achieve adequate analgesia.
Postoperative 2MWT was similar in both groups (P¼0.27). Six weeks after surgery,
recovery of 6MWT, physical activity, and knee function were significantly improved in
Group F (P,0.05). Preoperative walking capacity, physical activity and early total walking
time were the independent predictors of early recovery. Distance and time spent walking
were the predictors of functional walking exercise capacity at 6 weeks after surgery.
Conclusions. Femoral block is associated with lower opioid consumption and a better
recovery at 6 weeks than periarticular infiltration. Early postoperative activity measures
(2MWT and walking time) were proved to be possible indicators of knee function recovery
at 6 weeks after surgery.
Keywords: analgesia, postoperative; analgesic techniques, intra-articular; continuous
peripheral nerve block; morphine consumption; pain, acute; periarticular infiltration; total
knee arthroplasty
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Rehabilitation after total knee arthroplasty (TKA) routinely
starts immediately after surgery on the postoperative ward
and therefore requires adequate analgesia. An ideal analge-
sic modality for post-TKA rehabilitation should permit ade-
quate knee flexion with minimal pain and without motor
impairment, resulting in successful mobilization.1 Continuous
femoral nerve block (CFNB) with local anaesthetics has been
consistently shown to provide superior analgesia and less
side-effects compared with systemic opioids, thus facilitating
exercises to increase the degree of knee flexion.2–4 However,
a criticism of CFNB is that it may impair quadriceps muscle
strength through block of the femoral nerve, thus delaying
the ability to mobilize.
An alternative to CFNB involves periarticular infiltration of
the knee with high-volume local anaesthetics, providing
analgesia directly into the area of surgical trauma. After
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initial reports of success using periarticular infiltration of
high-volume local anaesthetics in TKA,5 recent open and ran-
domized studies have confirmed that this technique reduces
postoperative intensity of pain and consumption of rescue
analgesics.6–8 This accelerated recovery was attributed to
improved walking capacity and less quadriceps impairment.
Traditionally, the degree of knee flexion has been used as
an outcome measure after TKA to evaluate functional recov-
ery and the success of the type of analgesia used.2–9
However, with the need to accelerate hospital discharge
and shorten the period of rehabilitation,10–12 the capacity
to mobilize from a chair with minimal effort and walk a suffi-
cient distance with minimal aid represents a more realistic
criterion to assess functioning and independence after TKA.
Physical activity is an important aspect of day-to-day life,
and walking capacity is a measure of exercise tolerance
requiring muscle strength. Walk tests measure the distance
walked over a definite time period, with greater distances
indicating better performance. The 6 min walk test (6MWT)
and the 2 min walk test (2MWT), respectively, reflect endur-
ance and muscle force required to walk effectively.13 14
Although CFNB and periarticular infiltration have both
been associated with superior analgesia and favourable
knee flexion compared with systemic opioids, no random-
ized, double-blind study has yet been performed to
compare the effect of these two techniques on postoperative
walking capacity and this measure of mobility is assumed to
be an index of postoperative recovery. In fact, the only pre-
vious randomized study comparing CFNB with periarticular
infiltration was not double blinded and did not use standar-
dized measures of walking capacity and physical activity.15
This prospective, double-blind, randomized, single-centre
trial was designed to compare the quality of analgesia
offered by CFNB and periarticular infiltration and their
impact on 6MWT and 2MWT performance in both the post-
operative period and 6 weeks after surgery. The potential
for preoperative and immediately postoperative functional
walking capacity to predict late recovery was also assessed.
In line with the current literature, it was hypothesized that
periarticular infiltration of local anaesthetics would improve
functional exercise capacity in both the early and the late
postoperative period compared with CFNB.
Methods
A prospective, randomized, double-blind, controlled, single-
centre trial was carried out at the McGill University Health
Centre (MUHC). The data for this study came from persons
undergoing a primary, unilateral, tricompartmental cemen-
ted TKA between February 2007 and November 2008. The
study was approved by the MUHC Research Ethics Board
(GEN#06-026) and all subjects signed a written informed
consent form. At the time of study approval, registration in
a clinical trials database was not required.
Subjects
Persons were eligible to enter the study if they were over
the age of 18 and were referred for TKA secondary to
osteoarthritis. Exclusion criteria were: ASA health status
class IV–V, history of abnormal liver enzymes, hepatic
failure, renal insufficiency, cardiac failure, organ transplant,
morbid obesity (BMI.40 kg m22), neuropathic pain, history
of stroke or major neurological deficit, sensory and motor dis-
orders in the operated limb, previous drug dependency,
chronic use of opioids, allergy to local anaesthetics, inability
to walk independently, and inability to comprehend pain
assessment. Patients were instructed before surgery in the
use of the numerical rating scale (NRS) to assess pain.
Anaesthesia
Standard monitoring (pulse oximeter, ECG, and non-invasive
arterial pressure) was applied to all patients on their arrival in
the anaesthetic room. No premedication was given. After an
i.v. preload with 500 ml of 0.9% NaCl, a spinal block was per-
formed in sitting position with either a 25 or 27 G Whitacre
spinal needle inserted at the L2–L3 or L3–L4 intervertebral
space. After clear free flow of cerebrospinal fluid, 12.5 mg
of racemic 0.5% bupivacaine was administered to achieve
sensory block (to cold and pinprick) to the 10th thoracic der-
matome or above. Throughout surgery, sedation, if necess-
ary, was achieved with a continuous infusion of propofol.
Intravenous normal saline (0.9% NaCl) was administered
during the surgery at an hourly rate of 6–8 ml21, and intra-
operative normothermia (.36.08C) was maintained with
warming blankets spread over the exposed part of the
body. Hypotension (arterial pressure ,80 mm Hg) was
treated with i.v. bolus doses of 100 mg of phenylephrine.
Oxygen therapy (30% oxygen mask) was provided to all
patients during the first 24 h.
Surgical care
All surgeries were performed by a single surgeon (M.T.). One
dose of 2 g of cefazolin (GlaxoSmith Kline, England) was
given i.v. 30 min before surgery and then every 8 h for a
total of three doses. A pneumatic tourniquet was positioned
on the thigh before surgery and inflated to 250 mm Hg. The
surgical technique involved approaching the knee through a
midline incision with a medial parapatellar arthrotomy. All
varus/valgus deformities were then corrected using appropri-
ate soft tissue releases. The anterior cruciate ligament was
resected and the posterior cruciate ligament was preserved
with a bony island. An intramedullary alignment guide was
used to prepare the femur, whereas the proximal tibia was
cut using an extramedullary guide. The patella was not
everted for exposure or preparation in any case. All patients
received a NexGen cruciate retaining TKA with patellar resur-
facing (Zimmer, Warsaw, IN, USA). All components were
cemented in place using Simplex P cement with tobramycin
(Stryker, Rutherford, NJ, USA) that had been pressurized into
the cut surfaces using a cement gun.
Analgesic techniques
All patients received a femoral nerve catheter and a periarti-
cular knee catheter.
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Continuous femoral nerve catheter
All femoral nerve catheters were inserted before spinal anaes-
thesia by one investigator (J.F.A.). Under aseptic conditions,
a stimulating catheter (Stimucath, Arrow International,
Reading, PA, USA) was used in all blocks. The femoral nerve
was localized 1 cm lateral to the femoral artery at the inguinal
crease and identified by a quadriceps motor response and
ascension of patella. The catheter was then threaded with
caution to maintain at all times the desired motor response.
The threshold accepted for final catheter positioning was
,0.8mAof current intensity (0.1mswidth, 2 Hz). The catheter
was then tunnelled for 5–7 cm under the skin tominimize dis-
lodgement. At the end of surgery, patients received a loading
dose of 8ml of either ropivacaine 0.2% (Group F) or saline 0.9%
(Group I). This was followed by a continuous infusion of either
ropivacaine 0.2% (Group F) or saline 0.9% (Group I) at a rate of
8 ml h21 for 48 h.
Infiltration of the posterior capsule of the knee to cover
popliteal pain
A solution containing 100 mg of ropivacaine (50 ml of ropiva-
caine 0.2%), 0.5 ml of ketorolac (30 mg ml21), and 0.25 ml of
epinephrine (1 mg ml21) was injected into the posterior
capsule of the knee. This was done after all the bony cuts
and before cementing the implants. This allowed wide
exposure of the posterior capsule and thereby allowing
diffuse infiltration of the capsule. This solution was adminis-
tered to all patients irrespective of the group, and it was done
to make the two groups similar with regard to the popliteal
pain which can normally occur in 15–20% of patients under-
going TKA.
Periarticular and intra-articular infiltration
A second solution containing a total volume of 100 ml of
ropivacaine 0.2%, 1 ml of ketorolac (30 mg ml21), and 0.5
ml of epinephrine (1 mg ml21) was prepared to be infiltrated
in Group I. An equivalent amount of saline 0.9% was also
prepared to be infiltrated in Group F. These solutions were
injected into the remainder of the capsule, the cut quadri-
ceps tendon, the patellar ligament and soft tissues surround-
ing the joint, and the s.c. tissues after closure of the medial
parapatellar arthrotomy.
At the end of surgery, an intra-articular 3.2 mm catheter
tubing (Wound-EvacTM, Microtek, Dominican Republic) was
inserted 5 cm proximal to the incision into the distal anterior
thigh, penetrating the s.c. tissues, the quadriceps muscle,
and the joint capsule, with the catheter tip running along
the lateral gutter of the knee joint. Through this catheter, a
third solution containing either 50 ml of ropivacaine 0.5%
with ketorolac (30 mg ml21) and 0.25 ml of epinephrine
(1 mg ml21) or saline 0.9% was infused in Group I and
Group F, respectively, over a 2 h period at 24 h after the
end of operation. At the end of the infusion, the catheter
was immediately removed and a pressure bandage applied.
Randomization
On themorning of surgery, patients were randomized to one of
the two groups, continuous femoral nerve block (Group F) and
periarticular infiltration (Group I) using computer-generated
tables and sealed brown envelopes. The solutions for both
femoral and periarticular infiltration were prepared under
aseptic conditions. The staff involved in the clinical care (sur-
geons, anaesthetists, nurses, and physiotherapists) and the
patients were not aware of the treatment group assignment.
Multimodal analgesia
At arrival in the post-anaesthesia care unit (PACU), all
patients in both groups were connected to a patient-
controlled analgesia (PCA) pump set-up to deliver incremen-
tal doses of 1 mg of morphine, with a lockout of 7 min and no
background infusion. The PCA was discontinued 48 h after
surgery, and all patients received slow-release oxycodone
10 mg p.o. every 12 h. For breakthrough pain with NRS .3,
oxycodone 5–10 mg p.o. every 3 h was prescribed for
3 days. Both groups started to receive in the PACU celecoxib
100 mg every 12 h for 5 days and acetaminophen 1 g every
6 h for 5 days. Patients with postoperative nausea and vomit-
ing (PONV) received i.v. ondansetron 2–4 mg and i.v. dymen-
hydrate (Gravol) 50 mg as needed.
Postoperative care
No patients were placed on a fast track rehabilitation proto-
col. The patients were visited by the surgical team that was
responsible for postoperative care and that was unaware of
the results of the clinical or objective assessments. This
team recorded daily knee function (flexion, wound bleeding,
infection, and pain) and also determined the readiness for
discharging patients from hospital according to standard cri-
teria (patients able to ambulate with some assistance, ability
to climb stairs, tolerance of solid food, absence of infection,
and NRS at rest ,3 out of 10). The i.v. infusion of crystalloids
was discontinued on the postoperative day (POD) 1 if no
complications (PONV and bleeding) occurred. Full diet was
allowed as soon as the patients arrived on the surgical
ward. A urinary catheter was not inserted before surgery.
Bladder volume was monitored after surgery using a bladder
scanner, and if the volume of urinewas above 500ml, patients
would receive an in–out bladder catheterization. If they were
not able to void after one in–out catheterization, the bladder
catheter would be left in situ for 24 h.
Physiotherapy protocol
Under physiotherapist’s supervision and in a progressive
manner, the following interventions and exercises were
undertaken daily (between 12:00 and 15:00 h) while in hos-
pital: body mechanics, bed mobility, out of bed transfer,
assisted ambulation, stair training, deep breathing and
coughing exercises, flexion and extension of non-operated
knee, static quadriceps, and assisted flexion exercises for
the operated leg. Maximum knee flexion and pain intensity
(NRS 0–10) during knee flexion were recorded. The
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physiotherapist, in consultation with the surgeon, was also in
charge of organizing the discharge either to home or to a
rehabilitation centre.
Outcome measures
Analgesia
The quality of postoperative pain relief was estimated by daily
consumption ofmorphine during the first 48 h and the NRS for
pain (11-point scale 0–10 where 0 means no pain and 10
extreme pain) at rest, on walking, and on knee maximal
flexion for each of the first 3 days, at the time of hospital dis-
charge, and 6 weeks after surgery. The degree of knee flexion
was measured by the physiotherapist with a goniometer, and
pain intensity during knee assessment was assessed during
the early afternoon hours for the first three PODs. The inci-
dence of PONV was recorded for the first 48 h.
Functional walking capacity
The 2MWTand 6MWT were used to assess functional walking
capacity.16 The 2MWT was measured before surgery and in
the early afternoon (between 13:00 and 17:00 h) of the
first, second, and third PODs to assess muscle strength and
the obstacles to walking recovery. The 6MWT was measured
before surgery and at 6 weeks after surgery to assess endur-
ance. The distance covered was then recorded in metres. If
the patient was unwilling or unable to walk, the reason
was recorded for that day. Baseline-predicted 2MWT and
6MWT distance was calculated using gender-specific refer-
ence equations for the 6MWT.17
Physical activity
Activity while in hospital was recorded as the total time out
of bed either sitting or walking during the first three PODs in
a journal by all patients. Also time to first full diet and first
walk was recorded. To assess the amount of physical activity
before and 6 weeks after surgery, patients were asked to fill
the Community Health Activities Model Program for Seniors
(CHAMPS) questionnaire. This was developed to evaluate
the effectiveness of interventions to increase physical activity
in older adults.18 The CHAMPS has construct validity and
been used in surgical patients to assess recovery.19
Health-related quality of life
This was measured by the acute (week recall) SF-12 health
survey.20
Assessment of knee function
The Western Ontario and McMaster Universities Osteoar-
thritis Index (WOMAC)21 and the Knee Society evaluation22
were administered before and 6 weeks after surgery.
Data collection
All characteristic and clinical data related to patients’
outcome measures (primary, secondary, and intermediate)
during the immediate and late postoperative period were
collected by a research assistant unaware of the study
hypothesis. Length of hospital stay and readmission rate
were also recorded, and postoperative complications up to
30 PODs were fully documented.
Power of the study
The primary outcome was morphine consumption during the
first 48postoperativehours. On thebasis of the values reported
in two separate studies on TKA and comparing periarticular
infiltration vs PCA morphine and similarly femoral block vs
PCA morphine, 36 patients would be required to detect a sig-
nificant difference between Group F (n¼18) and Group I
(n¼18) .40% in morphine consumption with a power of
80% and an a of 5%.6 23 To allow for protocol violations or
increased variability in data, 40 patients in totalwere recruited.
Data analysis
Statistical analysis was performed using Stata Version 9.2
software (Stata Corporation, College Station, TX, USA). The
clinical data of the population studied are presented in
Table 1, and normally distributed continuous variables were
Table 1 Patients characteristics and clinical data presented as
mean (range) for age and mean (SD), absolute number, or median
(IQR) as appropriate for other variables. ASA, American Society of
Anesthesiologists
Variables Periarticular
infiltration
(n520)
Femoral block
(n520)
Age (yr) 70.8 (55–85) 71.1 (56–84)
Weight (kg) 75.8 (9.0) 74.3 (17.6)
Height (cm) 163.3 (8.1) 165.6 (10.1)
Body mass index (kg m22) 28.5 (3.3) 27.0 (5.2)
Sex, M/F 5/15 6/14
ASA status I/II/III 1/14/5 1/17/2
Co-morbidities
None 8 9
Hypertension 6 11
Coronary artery disease 2 1
Atrial fibrillation 1 0
Hypercholesterolaemia 1 4
Hypothyroidism 1 1
Asthma 0 1
Diabetes 3 2
Gastric ulcer 1 0
Side of surgery, R/L 11/9 11/9
Surgery time (min) 105 (95–110) 118 (108–127)
Tourniquet (min) 97 (90–102) 102 (89–111)
Tourniquet (mm Hg) 275 (250–275) 260 (250–275)
Intraoperative blood loss
(ml)
200 (125–250) 200 (125–300)
Intraoperative fluids
administered (ml)
1500
(1000–1500)
1550 (1100–2000)
Time to eating (h) 7 (4–16) 10 (4–18)
Time to walking (h) 24 (24–48) 24 (24–37)
Hospital length of stay (days) 5 (4–6) 5 (4–6)
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compared using Student’s t-test. Other data were compared
using Pearson’s x2 test or Wilcoxon’s rank sum test, when
appropriate. The early postoperative outcomes (Tables 2
and 3) were analysed with repeated-measures regressions
for general linear models, after transformation of non-
normally distributed variables into normal, or with repeated-
measures Poisson’s regressions for NRS pain. For the late
outcomes (Table 4), Student’s t-test or Wilcoxon’s rank sum
test was used with unmatched approach for the comparisons
between groups and with matched approach for the com-
parisons within groups (preoperative vs 6-week measure-
ments). We evaluated the prediction of early and late
postoperative outcomes with pre- and perioperative indi-
cators by building a post hoc multiple linear regression
model using a stepwise approach. First, Spearman’s non-
parametric correlations were made for 65 preoperative
variables and two functional measures of recovery: the
improvement in 2MWT between POD1 and POD3 (early
Table 2 Rescue analgesic morphine and pain intensity presented as median (IQR). Morphine consumption values were transformed into normal
distributions and analysed with repeated-measures regressions for general linear models. NRS comparisons were made by repeated-measures
Poisson’s regressions. NRS, numeric rating scale; POD, postoperative day
Variables Periarticular infiltration (n520) Femoral block (n520) P-value between groups
Patient-controlled analgesia (morphine mg)
POD1 26.0 (13.0–43.0) 14.5 (6.5–31.1) 0.02
POD2 22.5 (11.0–33.5) 12.0 (2.5–26.0)
P-value within groups ,0.01
NRS for pain at rest
POD1 5 (2–5) 2 (1–5) 0.09
POD2 3 (0–5) 1 (0–3)
P-value within groups ,0.01
NRS for pain on walking
POD1 5 (4–8) 5 (4–7) 0.69
POD2 5 (3–6) 5 (3–6)
P-value within groups 0.15
NRS for pain at greatest knee flexion
POD1 7 (7–8) 7.5 (5–8.5) 0.18
POD2 8 (6–9) 7 (5.5–8)
P-value within groups 0.78
Table 3 Early functional outcomes reported as mean (SD) or median (IQR), according to the raw variable distribution. All non-normally
distributed variables were transformed into normal distributions for analysis. All comparisons were made by repeated-measures regressions for
general linear models. POD, postoperative day
Variables Periarticular infiltration (n520) Femoral block (n520) P-value between groups
2 min walking test (m)
POD1 14.7 (6.2) 11.2 (7.7) 0.27
POD2 21.8 (9.5) 19.1 (12.5)
POD3 30.6 (12.3) 26.9 (15.6)
P-value within groups ,0.01
Out of bed time—sitting (min)
POD1 22.5 (10.0–67.5) 25.0 (15.0–75.0) 0.72
POD2 60.0 (15.0–120.0) 60.0 (52.5–120.0)
P-value within groups ,0.01
Out of bed time—walking (min)
POD1 2.0 (0.0–5.0) 5.0 (0.0–10.0) 0.04
POD2 10.0 (2.0–10.0) 10.0 (5.0–17.5)
P-value within groups ,0.01
Maximal knee flexion (8)
POD1 70.0 (57.5–75.0) 70.0 (57.5–80.0) 0.38
POD2 80.0 (74.5–83.0) 79.5 (72.5–84.5)
P-value within groups ,0.01
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recovery), and the absolute value of 6MWT at 6 weeks (late
recovery). Variables significantly related to these measures
of recovery in the bivariate analysis, if non-normally distribu-
ted, were then transformed to produce normal distributions.
Variables that were significant on this initial analysis were
entered into multiple linear regression models built with a
stepwise approach. This allowed us to identify variables inde-
pendently related to the two established measures of recov-
ery (Table 5). Data are expressed as mean [standard
deviation (SD)], median [inter-quartile range (IQR)], or absol-
ute numbers, when appropriate. A value of P,0.05 was con-
sidered statistically significant for all comparisons.
Results
Patients and clinical care
The flowof patients through the study is shown in Figure 1. The
patient characteristics and clinical data related to surgery of
the two groups were comparable except for a longer duration
of surgery in Group F (Table 1). Twopatients, one in eachgroup,
had a haematoma in the operative knee joint; however,
neither of thesewas sufficiently severe to require surgical drai-
nage. A second patient in Group I had atrial fibrillation on the
POD2 and was treated successfully with medical therapy. No
infection occurred. There were no hospital readmissions
during the first 30 PODs.
Pain relief
Patients in Group F used less morphine than Group I during
the first two PODs (Table 2). There was a trend to less pain
at rest in the F group, but on walking, the NRS was similar
between the two groups. There were also no differences in
NRS pain at greatest knee flexion between groups on the
first and second PODs. The incidence of PONV was similar in
both groups on day 1, but was greater in Group F on day 2
(six out of 20 in Group F vs one out of 20 in Group I,
P¼0.037).
Table 4 Late functional outcomes presented as mean (SD) or median (IQR). Comparisons were made by Student’s t-test or Wilcoxon’s rank sum
test, when appropriate. Tests for matched data were used for within-group analysis, whereas tests for unmatched data were used between
groups. CHAMPS, Community Health Activities Model Program for Seniors; SF-12, short-form health-related quality of life; PCS, physical
component summary; MCS, mental component summary; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index
Variables Periarticular infiltration (n520) Femoral block (n520) P-value between groups
6 min walk test (m)
Preoperative 229.0 (89.3) 231.6 (81.3) 0.93
6 weeks 248.0 (87.4) 267.5 (82.3) 0.48
P-value within groups 0.38 0.01
CHAMPS (kcal kg21 week21)
Preoperative 20.4 (4.9–49.2) 23.0 (7.9–46.1) 0.59
6 weeks 29.5 (16.3–56.9) 54.2 (13.4–89.3) 0.28
P-value within groups 0.19 0.03
SF-12
Preoperative PCS 30 (26–35) 32 (27–36) 0.37
6 weeks PCS 42.4 (11.1) 43.2 (8.9) 0.79
P-value within groups 0.01 0.01
Preoperative MCS 51.6 (11.4) 51.2 (10.9) 0.92
6 weeks MCS 57 (48–61) 56 (53–58) 0.79
P-value within groups 0.33 0.11
Knee Society evaluation
Preoperative 92.2 (24.0) 95.3 (27.4) 0.71
6 weeks 137.7 (33.7) 156.6 (24.2) 0.05
P-value within groups 0.01 ,0.01
WOMAC
Preoperative 53.7 (14.7) 52.0 (13.6) 0.71
6 weeks 28.0 (14.2) 19.7 (10.6) 0.04
P-value within groups ,0.01 ,0.01
Maximal knee movement (8)
Preoperative extension 5 (0–11) 10 (0–10) 0.80
6 weeks extension 0 (0–1) 0 (0–0) 0.40
P-value within groups 0.02 0.01
Preoperative flexion 116 (111–120) 117 (110–120) 0.94
6 weeks flexion 107 (98–114) 110 (105–118) 0.15
P-value within groups ,0.01 0.49
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Early postoperative functional outcome measures
The 2MWT decreased significantly after surgery from pre-
operative values in both groups (286.7% for Group F and
283.1% for Group I) and recovered over the first 3 days
9.02 (SD 4.46) m day21 for Group F and 8.37 (5.04) m day21
for Group I (Table 3, Fig. 2). These changes were not different
between the two groups. Seven patients in Group I (35%) and
six in Group F (30%) did neither walk nor performed the
Table 5 Multivariate linear regressions on recovery variables. Values are regression coefficient, 95% confidence interval, and P-value of
multivariate linear regression. Predictive ability is showed as R2 coefficient. 2MWT, 2 min walk test; POD, postoperative day; ASA, American
Society of Anesthesiologists; 6MWT, 6 min walk test
Coefficient 95% CI P-value R2
2MWT recovery (DPOD3–POD1)
Weight 0.27 (0.07/0.48) 0.01 69.56
ASA II 210.58 (220.75/20.42) 0.04
ASA III 213.64 (227.76/0.47) 0.06
Log (preoperative 2MWT) 10.33 (3.13/17.52) 0.01
Out of bed walking total time (POD1+2+3) 0.21 (0.05/0.38) 0.02
Constant 246.56 (283.20/29.91) 0.02
6MWT at 6 weeks
Log (preoperative 6MWT) 130.34 (70.57/190.10) ,0.01 53.20
Patients who performed the 2MWT at POD1 54.70 (5.33/104.06) 0.03
p
Out of bed walking time in POD2 34.90 (10.33/59.48) 0.01
Out of bed walking total time (POD1+2+3) 22.35 (24.42/20.28) 0.03
Constant 2511.75 (2827.88/2195.61) 0.01
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Assessed for eligibility (n=51)
En
ro
lm
en
t
Al
lo
ca
tio
n
Randomized (n=40)
Excluded (n=11)
 Not meeting inclusion criteria (n=3)
 Refused to participate (n=7)
 Other reasons (n=1)
Allocated to intervention (n=20)
 Received intervention (n=20)
 Did not receive intervention (n=0)
Fo
llo
w
-u
p
Lost to follow-up (n=0)
 Discontinued intervention (n=0)
Lost to follow-up (n=0)
 Discontinued intervention (n=0)
An
al
ys
is Analysed (n=20)
 Excluded from analysis (n=0)
Analysed (n=20)
 Excluded from analysis (n=0)
Allocated to intervention (n=20)
 Received intervention (n=20)
 Did not receive intervention (n=0)
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2MWT on POD1 for multiple reasons: pain (6), dizziness (5),
tiredness (5), bleeding (2), and swollen knee. All patients
walked on days 2 and 3. The number of patients ambulating
over 30 m on day 2 in Group I were six out of 20 (30%) and in
Group F three out of 20 (15%), and on day 3 were 11 (55%) in
Group I and eight (40%) in Group F, with no differences
between the two groups.
Time out of bedwalking during the first two PODs increased
significantly in both groups, with Group F spending a signifi-
cantly longer time walking compared with Group I.
Other functional measures (out of bed time sitting and
maximal knee flexion) were not different between the two
groups.
Late postoperative functional outcome
The preoperative 6MWT was similar in both groups, being
approximately the 37% of age-gender appropriate predicted
scores (Table 4). When repeated 6 weeks after surgery, 6MWT
scores increased in Group F (+15.5%) but not significantly in
Group I (+8.3%).
Reported amount of physical activity as assessed by
CHAMPS showed a significant increase in Group F
(+135.7%) but not significantly in Group I (+44.6%) 6
weeks after surgery compared with preoperative values.
The physical component of the SF-12 increased signifi-
cantly in both groups (+35.0% for Group F and +41.3% for
Group I) at 6 weeks compared with baseline. There were no
changes in the mental component of the SF-12.
The Knee Society evaluation decreased significantly in
both groups 6 weeks after surgery (+64.3% in Group F and
+49.3% in Group I); the comparisons between measure-
ments made 6 weeks after surgery showed absolute values
significantly higher in Group F (P¼0.05).
Similarly, the changes in WOMAC scores over the first 6
postoperative weeks were statistically significant in both
groups (262.1% in Group F and 247.9% in Group I), with
absolute values significantly lower in Group F (P¼0.04).
Maximal knee extension improved in both groups at
6 weeks with no difference between the two groups.
Maximal knee flexion decreased significantly in Group I
(27.8%) but not significantly in Group F (26.0%), with no
differences between groups regarding absolute values.
Correlations between perioperative physiological
variables and immediate and late post-surgical
recovery indicators
Only four and three variables, respectively, for the two func-
tional outcomes were found independently and significantly
correlated with the 2MWT and the 6MWT, respectively
(Table 5). Body weight, ASA, preoperative 2MWT, and total
time out of bed during the first three PODs were the predic-
tors of the immediate recovery of 2MWT. Preoperative 6MWT,
ability to walk 24 h after surgery, and total time spent
walking during the first three PODs were the independent
predictors of the distance covered over 6 min at 6 weeks
after surgery.
Discussion
In this double-blind, randomized, controlled trial, CFNB was
associated with a significantly reduced postoperative con-
sumption of morphine and a trend to better analgesia com-
pared with periarticular infiltration. In addition, patients in
the CFNB group spent more time out of bed walking during
the first two PODs. Functional recovery at 6 weeks after
surgery was more favourable in the CFNB group which
showed a greater improvement in walking capacity, physical
activity, and indices of knee function.
The initial findings from non-randomized studies reporting
good quality of postoperative analgesia and opioid-sparing
effect achieved with periarticular infiltration of local anaes-
thetics for knee arthroplasty prompted clinicians to conduct
randomized, controlled studies comparing this technique
with systemic opioids in the context of multimodal analge-
sia.5–8 The positive findings would indicate that such a
simple technique could potentially accelerate the recovery
process and allow patients to be more mobile after surgery.
A recent study comparing the periarticular infiltration
technique with femoral block showed the superiority of
pain relief and less opioid consumption with periarticular
infiltration.15 This is in contrast with present findings where
the use of femoral block was associated with less morphine
consumption. Although a direct explanation for this discre-
pancy cannot be found, comparative analysis of results
reveals that no sciatic block was used and the breakthrough
administration of morphine was significantly greater than
previously used.6 7 Despite this difference, both the previous
and the current studies did use similar anaesthetic regimens
for both periarticular infiltration and CFNB, and used a com-
pressed bandage as suggested to help the spread of local
anaesthetic in the periarticular area.8
As a secondaryoutcome, this studyaimed to determine the
impact of postoperative analgesia on functional outcome.
Beside knee function, we wanted to assess walking capacity
and physical activity in the immediate postoperative period
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P<0.001 within groups
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Fig 2 2MWT results. Tests were performed before surgery and on
the first three PODs.
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and 6weeks after surgery. The 2MWTwasmeasured to assess
muscle force in the leg exerted when walking over a short
period of time.14 24 We did not administer the 6MWT in this
acute stage as it was thought that patients would not have
been able to walk for such a long period of time. This is
evident from the study by Ilfeld and colleagues25 in which
patients walked on average 40 m in 6 min on the second
POD, whereas ours walked over 20 m in 2 min.
Functional outcome at 6 weeks after surgery
Traditionally, outcome measures assessing knee function
during the postoperative period have been constructed
with the intent to assess mainly the range of motions specific
to the knee (WOMAC and the Knee Society)26 27 and the pain
associated with it. However, there has been an increasing
interest in assessing the capacity to ambulate, as this is
dependent upon muscle strength rather than range of
motion, and has been shown to be a critical determinant
of postoperative outcome after TKA.28 29 Although distance
has been used to determine readiness to discharge, this
test has not been standardized and depends on outside
influences. In contrast, the walk test is a reliable index of
exercise tolerance as it assesses submaximal exercise
capacity measured by a distance over a specific time using
a standardized protocol. The 6MWT was originally developed
to assess the disease progression in patients with chronic
respiratory diseases, but more recently, it has been used
and validated as a measure of recovery after surgical pro-
cedures24 30–32 as it integrates all components of functional
walking capacity such as balance, speed, and endurance in
one measure. It is easy to administer, has construct validity
and is sensitive to changes. Nevertheless, it can be influ-
enced by general health status, age, gender, and BMI.
In the present study, the CFNB group had a more favour-
able improvement at 6 weeks not only in the outcome
measures associated with mobilization and activity, 6MWT,
and CHAMPS, but also with the knee function (WOMAC and
the Knee Society). In the CFNB group, the walking distance
increased in 6 weeks by 35 m. This change was matched
by a 136% increase in physical activity (CHAMPS, kcal kg21
week21), with better WOMAC and the Knee Society scores.
Suchfindingsnot onlyconfirmthepositive impact ofanalge-
siaon lateoutcomemeasuresspecific toknee function,butalso
report the beneficial effects onmeasures of general health and
recovery such as physical activity and mobilization. This is the
first time that validated outcome measures of functional
walking capacity have been assessed in this surgical group.
Correlation between outcome measures and
prediction of functional recovery
As a post hoc analysis, in this paper, we also wanted to
determine whether, based on the model proposed by Carli
and Mayo,33 the biological and physiological short-term
changes would impact on long-term functional outcome.
The functional outcome chosen was the improvement in
2MWT between POD1 and POD3 (early recovery) and the
absolute value of 6MWT at 6 weeks (late recovery). These
are preliminary observations and need to be confirmed in
future and adequately powered studies. We found that
recovery in 2MWT was positively correlated with all indices
of functional activities (walk tests, CHAMPS, and the func-
tional component of the knee society) both in the periopera-
tive period and 6 weeks after surgery and pain intensity
during walking (negative correlation). As with the 2MWT,
the 6MWT was found to be well correlated at 6 weeks after
surgery not only with all the preoperative indices of func-
tional activity, but also with changes in walking time during
the first 72 h after surgery. Although the population
sample was small and the scope of the present investigation
was not to identify those individuals with poor functional
scores before surgery and predict the postoperative
outcome, the findings might stimulate more research in this
area and help to understand how important it is to assess
clinical and patient-reported characteristics in order to identify
those individuals who are at risk of postoperative poor
outcome.34 These findings would suggest that both the
2MWTand 6MWTcould represent reliable indices of both func-
tional exercise capacity and patient perception of knee func-
tion, although no correlation was found between the 2MWT
and 6MWT and measures of knee function (WOMAC, range
of motions, and the clinical component of the Knee Society).
There are some limitations with this study. Although care
was taken to blind all techniques, we are aware that injection
of ropivacaine to the back of the knee, the insertion of the
catheter into the knee and the infusion of saline 0.9% into
the femoral nerve are not necessarily the protocols used in
the current clinical practice. Both 2MWTand 6MWTmeasured
walking capacity at only one point in time and not throughout
the day. In addition, walking represents only one type of
activity and not a full range performed on a daily basis. In
view of this, we administered the CHAMPS to estimate phys-
ical activity at a variety of intensities and frequency based
on previous weeks. The CHAMPS before surgery and at
6 weeks were significantly correlated with walking capacity
and are consistent with previous reports in surgical18 and
non-surgical populations.35 36 Another limitation was that
we did not assess the impact of the femoral block on the dis-
tance covered during 2min and the ability to ambulate during
the first three PODs. The measurement of quadriceps muscle
strength would have provided an objective outcome;
however, such measurement requires specialized instru-
ments which are not easily portable to be used at the bedside.
Conclusions
Continuous femoral block provided superior analgesia over
the periarticular infiltration of high volume of local anaes-
thetics and was associated with more favourable recovery
of walking capacity, physical activity, and knee function.
The 2MWT and 6MWT are meaningful outcome measures of
exercise capacity and perception of knee functioning after
TKA. They are safe to administer and monitor the progression
of ambulation in the early postoperative period and are
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possible indicators of walking ability and physical activity at 6
weeks after surgery. Further studies need to be performed to
assess construct validity of these tests in this surgical model
over a longer period of rehabilitation and to determine
whether the preoperative measurement of walking capacity
would help in identifying patients at risk of poor postopera-
tive recovery.
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